Remove Biopharma Remove Consulting Remove Pharmaceutical manufacturing Remove Training
article thumbnail

How resilient is the global biopharma industry?

Pharmaceutical Technology

As the full consequences of the COVID-19 virus started to emerge, and many industries found themselves having to either suspend operations or move to remote working, the biopharma sector found itself on the front line facing unprecedented challenges. Manufacturing agility: Index score 6.5/10. R&D ecosystem - Index score 6.54/10.

article thumbnail

QMS market to value nearly $4b by 2030

European Pharmaceutical Review

A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97

article thumbnail

How can the pharma industry address the gap in talent recruitment and development?

pharmaphorum

This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Training and development. Staff development and training programmes were largely on pause during the pandemic. Harness technology. Embrace mobile learning.